FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2072034139> ?p ?o ?g. }

• W2072034139 endingPage "842" @default.
• W2072034139 startingPage "837" @default.
• W2072034139 abstract "Purpose We previously developed a multigene expression model of tumor radiation sensitivity index (RSI) with clinical validation in multiple independent cohorts (breast, rectal, esophageal, and head and neck patients). The purpose of this study was to assess differences between RSI scores in primary colon cancer and metastases. Methods and Materials Patients were identified from our institutional review board–approved prospective observational protocol. A total of 704 metastatic and 1362 primary lesions were obtained from a de-identified metadata pool. RSI was calculated using the previously published rank-based algorithm. An independent cohort of 29 lung or liver colon metastases treated with 60 Gy in 5 fractions stereotactic body radiation therapy (SBRT) was used for validation. Results The most common sites of metastases included liver (n=374; 53%), lung (n=116; 17%), and lymph nodes (n=40; 6%). Sixty percent of metastatic tumors, compared with 54% of primaries, were in the RSI radiation-resistant peak, suggesting metastatic tumors may be slightly more radiation resistant than primaries (P=.01). In contrast, when we analyzed metastases based on anatomical site, we uncovered large differences in RSI. The median RSIs for metastases in descending order of radiation resistance were ovary (0.48), abdomen (0.47), liver (0.43), brain (0.42), lung (0.32), and lymph nodes (0.31) (P<.0001). These findings were confirmed when the analysis was restricted to lesions from the same patient (n=139). In our independent cohort of treated lung and liver metastases, lung metastases had an improved local control rate compared to that in patients with liver metastases (2-year local control rate of 100% vs 73.0%, respectively; P=.026). Conclusions Assessment of radiation sensitivity between primary and metastatic tissues of colon cancer histology revealed significant differences based on anatomical location of metastases. These initial results warrant validation in a larger clinical cohort. We previously developed a multigene expression model of tumor radiation sensitivity index (RSI) with clinical validation in multiple independent cohorts (breast, rectal, esophageal, and head and neck patients). The purpose of this study was to assess differences between RSI scores in primary colon cancer and metastases. Patients were identified from our institutional review board–approved prospective observational protocol. A total of 704 metastatic and 1362 primary lesions were obtained from a de-identified metadata pool. RSI was calculated using the previously published rank-based algorithm. An independent cohort of 29 lung or liver colon metastases treated with 60 Gy in 5 fractions stereotactic body radiation therapy (SBRT) was used for validation. The most common sites of metastases included liver (n=374; 53%), lung (n=116; 17%), and lymph nodes (n=40; 6%). Sixty percent of metastatic tumors, compared with 54% of primaries, were in the RSI radiation-resistant peak, suggesting metastatic tumors may be slightly more radiation resistant than primaries (P=.01). In contrast, when we analyzed metastases based on anatomical site, we uncovered large differences in RSI. The median RSIs for metastases in descending order of radiation resistance were ovary (0.48), abdomen (0.47), liver (0.43), brain (0.42), lung (0.32), and lymph nodes (0.31) (P<.0001). These findings were confirmed when the analysis was restricted to lesions from the same patient (n=139). In our independent cohort of treated lung and liver metastases, lung metastases had an improved local control rate compared to that in patients with liver metastases (2-year local control rate of 100% vs 73.0%, respectively; P=.026). Assessment of radiation sensitivity between primary and metastatic tissues of colon cancer histology revealed significant differences based on anatomical location of metastases. These initial results warrant validation in a larger clinical cohort." @default.
• W2072034139 created "2016-06-24" @default.
• W2072034139 creator A5010264712 @default.
• W2072034139 creator A5029626497 @default.
• W2072034139 creator A5035589941 @default.
• W2072034139 creator A5052124202 @default.
• W2072034139 creator A5062612957 @default.
• W2072034139 creator A5067051192 @default.
• W2072034139 creator A5078916775 @default.
• W2072034139 creator A5090807936 @default.
• W2072034139 date "2015-07-01" @default.
• W2072034139 modified "2023-10-16" @default.
• W2072034139 title "Differences Between Colon Cancer Primaries and Metastases Using a Molecular Assay for Tumor Radiation Sensitivity Suggest Implications for Potential Oligometastatic SBRT Patient Selection" @default.
• W2072034139 cites W1528207664 @default.
• W2072034139 cites W1550771085 @default.
• W2072034139 cites W1867537813 @default.
• W2072034139 cites W1963798982 @default.
• W2072034139 cites W1976359085 @default.
• W2072034139 cites W2002807490 @default.
• W2072034139 cites W2003917401 @default.
• W2072034139 cites W2019607817 @default.
• W2072034139 cites W2019806781 @default.
• W2072034139 cites W2024501410 @default.
• W2072034139 cites W2030505692 @default.
• W2072034139 cites W2031702956 @default.
• W2072034139 cites W2045356660 @default.
• W2072034139 cites W2049119588 @default.
• W2072034139 cites W2050034556 @default.
• W2072034139 cites W2064414057 @default.
• W2072034139 cites W2069976078 @default.
• W2072034139 cites W2096079397 @default.
• W2072034139 cites W2105612888 @default.
• W2072034139 cites W2119442895 @default.
• W2072034139 cites W2125551462 @default.
• W2072034139 cites W2145754044 @default.
• W2072034139 cites W2147073272 @default.
• W2072034139 cites W2158789700 @default.
• W2072034139 cites W2165877571 @default.
• W2072034139 cites W2166446427 @default.
• W2072034139 cites W2166459387 @default.
• W2072034139 cites W2167105148 @default.
• W2072034139 cites W4239112513 @default.
• W2072034139 doi "https://doi.org/10.1016/j.ijrobp.2015.01.036" @default.
• W2072034139 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4481172" @default.
• W2072034139 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25838188" @default.
• W2072034139 hasPublicationYear "2015" @default.
• W2072034139 type Work @default.
• W2072034139 sameAs 2072034139 @default.
• W2072034139 citedByCount "76" @default.
• W2072034139 countsByYear W20720341392015 @default.
• W2072034139 countsByYear W20720341392016 @default.
• W2072034139 countsByYear W20720341392017 @default.
• W2072034139 countsByYear W20720341392018 @default.
• W2072034139 countsByYear W20720341392019 @default.
• W2072034139 countsByYear W20720341392020 @default.
• W2072034139 countsByYear W20720341392021 @default.
• W2072034139 countsByYear W20720341392022 @default.
• W2072034139 countsByYear W20720341392023 @default.
• W2072034139 crossrefType "journal-article" @default.
• W2072034139 hasAuthorship W2072034139A5010264712 @default.
• W2072034139 hasAuthorship W2072034139A5029626497 @default.
• W2072034139 hasAuthorship W2072034139A5035589941 @default.
• W2072034139 hasAuthorship W2072034139A5052124202 @default.
• W2072034139 hasAuthorship W2072034139A5062612957 @default.
• W2072034139 hasAuthorship W2072034139A5067051192 @default.
• W2072034139 hasAuthorship W2072034139A5078916775 @default.
• W2072034139 hasAuthorship W2072034139A5090807936 @default.
• W2072034139 hasBestOaLocation W20720341392 @default.
• W2072034139 hasConcept C121608353 @default.
• W2072034139 hasConcept C126322002 @default.
• W2072034139 hasConcept C126838900 @default.
• W2072034139 hasConcept C142724271 @default.
• W2072034139 hasConcept C143998085 @default.
• W2072034139 hasConcept C188816634 @default.
• W2072034139 hasConcept C2777714996 @default.
• W2072034139 hasConcept C2779013556 @default.
• W2072034139 hasConcept C2779720271 @default.
• W2072034139 hasConcept C2780283643 @default.
• W2072034139 hasConcept C2989005 @default.
• W2072034139 hasConcept C509974204 @default.
• W2072034139 hasConcept C526805850 @default.
• W2072034139 hasConcept C71924100 @default.
• W2072034139 hasConcept C72563966 @default.
• W2072034139 hasConceptScore W2072034139C121608353 @default.
• W2072034139 hasConceptScore W2072034139C126322002 @default.
• W2072034139 hasConceptScore W2072034139C126838900 @default.
• W2072034139 hasConceptScore W2072034139C142724271 @default.
• W2072034139 hasConceptScore W2072034139C143998085 @default.
• W2072034139 hasConceptScore W2072034139C188816634 @default.
• W2072034139 hasConceptScore W2072034139C2777714996 @default.
• W2072034139 hasConceptScore W2072034139C2779013556 @default.
• W2072034139 hasConceptScore W2072034139C2779720271 @default.
• W2072034139 hasConceptScore W2072034139C2780283643 @default.
• W2072034139 hasConceptScore W2072034139C2989005 @default.
• W2072034139 hasConceptScore W2072034139C509974204 @default.
• W2072034139 hasConceptScore W2072034139C526805850 @default.
• W2072034139 hasConceptScore W2072034139C71924100 @default.
• W2072034139 hasConceptScore W2072034139C72563966 @default.

• next